Published: 2023 | Last reviewed: May 2026
Recombinant Protein Expression in Mammalian Cells
Key Takeaways
- Aspect
- Details
- Expression Systems
- Transient, stable, and inducible expression systems each have distinct advantages
- Vector Selection
- Critical factors include promoter strength, selection markers, and tag positioning
- Transfection Methods
- Chemical transfection, electroporation, and viral transduction offer different efficiency/complexity tradeoffs
- Key Challenges
- Low expression levels, protein aggregation, and improper glycosylation
Optimal Cell Lines for Recombinant Protein Expression
At Cytion, we offer several mammalian cell lines that excel in recombinant protein production. The choice of cell line depends on your specific requirements, with HEK293T, CHO-K1, and HeLa cells being the most widely used options. Each cell line offers distinct advantages for different expression scenarios, from rapid protein production to stable long-term expression. Understanding the characteristics of these cell lines is crucial for selecting the optimal expression system for your specific protein of interest.
Expression Systems: Choosing the Right Approach
Vector Design for Mammalian Expression
Recombinant Protein Expression in Mammalian Cells: Key Elements
Optimal Cell Lines
Expression Systems
Transient
• Rapid results (24-72h)
• No selection required
• Variable expression
Stable
• Consistent expression
• Higher yields
• More time investment
Inducible
• Control over timing
• For toxic proteins
• Reduced selection pressure
Vector Design
Critical elements:
- Promoter: CMV, EF1α, CAG
- Selection: Neo, Puro, Hygro
- Tags: His, FLAG, GST
- Position: N or C-terminal
Optimizing these key factors will maximize your recombinant protein expression success
Transfection Methods for Mammalian Cells
Troubleshooting Common Challenges in Mammalian Expression Systems
Despite their advantages, mammalian expression systems can present several key challenges that may require troubleshooting. Low expression levels are frequently encountered and can be addressed by optimizing codon usage for mammalian cells, testing different promoters, or implementing strategies such as sodium butyrate treatment to enhance transcription. Protein aggregation often indicates folding issues, which may be mitigated by reducing the culture temperature (30-34°C), co-expressing molecular chaperones, or modifying buffer conditions during purification. Improper glycosylation patterns can significantly impact protein function and immunogenicity, particularly for therapeutic applications; this challenge may be overcome by selecting more appropriate cell lines (such as CHO-K1 for biopharmaceuticals), supplementing the medium with specific precursors, or using glycoengineered cell lines. At Cytion, our technical support team can help you navigate these common challenges and develop an optimized expression strategy for your specific protein of interest, ensuring consistent production of high-quality recombinant proteins with proper folding and post-translational modifications.